Moreover, the PD‐1 platelets could be efficient cargo carriers for cyclophosphamide, an immunosuppressive drug, and improving anticancer immune response by depleting regulatory T cells (Tregs) within the tumor microenvironment. This evidence concerns the gene PDCD1 and neoplasm.